This trial is testing a new contraceptive pill, MR-100A-01, to see if it is effective, safe, and well-tolerated by women.
1 Primary · 10 Secondary · Reporting Duration: 12 months (13 cycles)
Experimental Treatment
1200 Total Participants · 1 Treatment Group
Primary Treatment: MR-100A-01 · No Placebo Group · Phase 3
Age Any Age · Female Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: